Iron replacement therapy: do we need new guidelines?

Ole Haagen Nielsen, Mehmet Coskun, Günter Weiss

12 Citationer (Scopus)

Abstract

PURPOSE OF REVIEW: Approximately, one-third of the world's population suffers from anemia, and at least half of these cases are because of iron deficiency. With the introduction of new intravenous iron preparations over the last decade, uncertainty has arisen when these compounds should be administered and under which circumstances oral therapy is still an appropriate and effective treatment.

RECENT FINDINGS: Numerous guidelines are available, but none go into detail about therapeutic start and end points or how iron-deficiency anemia should be best treated depending on the underlying cause of iron deficiency or in regard to concomitant underlying or additional diseases.

SUMMARY: The study points to major issues to be considered in revisions of future guidelines for the true optimal iron replacement therapy, including how to assess the need for treatment, when to start and when to stop treatment, when to follow-up for relapse, which dosage and type of therapy should be recommended or not recommended, and if some patients should not be treated.

OriginalsprogEngelsk
TidsskriftCurrent Opinion in Gastroenterology
Vol/bind32
Udgave nummer2
Sider (fra-til)128-135
Antal sider8
ISSN0267-1379
DOI
StatusUdgivet - 1 mar. 2016

Fingeraftryk

Dyk ned i forskningsemnerne om 'Iron replacement therapy: do we need new guidelines?'. Sammen danner de et unikt fingeraftryk.

Citationsformater